These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8108907)

  • 41. Ganciclovir prophylaxis to prevent CMV disease in kidney recipients undergoing anti-lymphocyte globulin treatment for acute rejection.
    Dickenmann MJ; Kabulbayev K; Steiger J; Cathomas G; Reusser P; Tamm M
    Clin Microbiol Infect; 2004 Apr; 10(4):337-9. PubMed ID: 15059125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ganciclovir prophylaxis delays but does not prevent cytomegalovirus infection in renal transplant recipients.
    Israni A; Krok K; Cohen D; Blumberg E; Bloom RD
    Transplant Proc; 2004 Dec; 36(10):3019-24. PubMed ID: 15686685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined foscarnet -ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (Hsct).
    Bacigalupo A; Bregante S; Tedone E; Isaza A; Van Lint MT; Moro F; Trespi G; Occhini D; Gualandi F; Lamparelli T; Marmont AM
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():110-4. PubMed ID: 8932810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of ganciclovir in renal transplant children.
    Jacqz-Aigrain E; Macher MA; Sauvageon-Marthe H; Brun P; Loirat C
    Pediatr Nephrol; 1992 Mar; 6(2):194-6. PubMed ID: 1315149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New developments in the management of cytomegalovirus infection and disease after renal transplantation.
    Kletzmayr J; Kreuzwieser E; Klauser R
    Curr Opin Urol; 2001 Mar; 11(2):153-8. PubMed ID: 11224745
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cytomegalovirus infections after renal transplant].
    Solá R; Caralps A; Andreu J; Ricart MJ; Brulles A; Vilardell J; Oppenheimer F; Gil Vernet JM; Beltrán M
    Rev Clin Esp; 1980 Dec; 159(5):349-54. PubMed ID: 6261312
    [No Abstract]   [Full Text] [Related]  

  • 47. Myocarditis caused by cytomegalovirus infection in a child with a renal transplant.
    Bircan ZE; Buyan N; Olguntürk R; Söylemezoğlu O; Tunaoğlu S; Hasanoğlu E
    Nephrol Dial Transplant; 1994; 9(12):1803-4. PubMed ID: 7708269
    [No Abstract]   [Full Text] [Related]  

  • 48. [Cytomegalic ulcer in the caecum after renal transplantation (author's transl)].
    Clavadetscher P; Sulser H; Linder E; Deyhle P
    Dtsch Med Wochenschr; 1974 Oct; 99(40):1970-2. PubMed ID: 4369529
    [No Abstract]   [Full Text] [Related]  

  • 49. Cytomegalovirus syndrome post-renal transplantation. Treatment with cytosine arabinoside.
    Fine RN; Malekzadeh M; Grushkin CM; Wright HT
    Calif Med; 1973 Mar; 118(3):46-9. PubMed ID: 4347632
    [No Abstract]   [Full Text] [Related]  

  • 50. [Case of probable central nervous system cytomegaly developing in the course of long-term immunosuppressive treatment].
    Marks E; Zuzewicz W; Wolska E
    Wiad Lek; 1975 Aug; 28(15):1325-8. PubMed ID: 169637
    [No Abstract]   [Full Text] [Related]  

  • 51. Cytomegalovirus encephalitis in a kidney transplant recipient.
    Guerraoui A; Grezard O; Cottier JP; Nivet H; Bagros P; Lebranchu Y
    Nephrol Dial Transplant; 1994; 9(3):329-30. PubMed ID: 8052445
    [No Abstract]   [Full Text] [Related]  

  • 52. Cytomegalovirus infections, kidney transplantation, and secondary hemophagocytic lymphohistiocytosis.
    Cascio A; Famà F; Mondello P; Barberi G; Pernice LM; Iaria C
    Transpl Infect Dis; 2014 Dec; 16(6):1039-41. PubMed ID: 25219298
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients.
    Hosseini-Moghaddam SM; Rotstein C; Husain S
    Am J Transplant; 2011 Feb; 11(2):407. PubMed ID: 21219565
    [No Abstract]   [Full Text] [Related]  

  • 54. [Cytomegalovirus after renal transplantation - diagnosis, prevention and treatment].
    Kliem V; Sester M; Nitschke M; Tönshoff B; Budde K; Hauser IA; Schmitt M; Höcker B; Witzke O
    Dtsch Med Wochenschr; 2015 Apr; 140(8):612-5. PubMed ID: 25945912
    [No Abstract]   [Full Text] [Related]  

  • 55. Cytomegalovirus balanitis in a renal transplant recipient.
    Rodriguez A; Hill B; Gopolan R; Sklar GN
    J Urol; 1999 Dec; 162(6):2086. PubMed ID: 10569577
    [No Abstract]   [Full Text] [Related]  

  • 56. A patient with two distinct episodes of cytomegalovirus disease after renal transplantation.
    Bosch FH; Hoitsma AJ; Koene RA
    Nephrol Dial Transplant; 1989; 4(3):238-9. PubMed ID: 2542842
    [No Abstract]   [Full Text] [Related]  

  • 57. Recurrent cytomegalovirus infection: prevalence and risk factors.
    Einollahi B; Motalebi M
    Iran J Kidney Dis; 2014 May; 8(3):168-70. PubMed ID: 24878937
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cytomegaly in the newborn-etiopathogenesis, clinical aspects and therapy].
    Tsvetkov G
    Akush Ginekol (Sofiia); 1970; 9(1):74-80. PubMed ID: 4316402
    [No Abstract]   [Full Text] [Related]  

  • 59. [Immunosuppressive treatment: administration, adverse effect, prophylactic measures].
    Sibilia J; Carles P
    Rev Mal Respir; 2006 Dec; 23(6):759-63. PubMed ID: 17886355
    [No Abstract]   [Full Text] [Related]  

  • 60. CMV management in a post-kidney-transplant child.
    Elshihabi I
    Transplant Proc; 1994 Feb; 26(1):131. PubMed ID: 8108907
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.